Multidrug resistance in lung allograft recipients: possible correlation with the development of acute and chronic rejection

J Heart Lung Transplant. 1993 Jan-Feb;12(1 Pt 1):20-6.

Abstract

The expression of drug resistance antigens in mononuclear inflammatory cells was studied in transbronchial lung biopsy specimens of lung allograft recipients who experienced steroid-sensitive and steroid-resistant bouts of acute rejection and bronchiolitis obliterans. Immunostains for C494 and C219 epitopes of p-glycoprotein and human metallothionein revealed that (1) mononuclear cells expressing these antigens are present in the lung allograft during rejection, (2) that steroid-resistant acute rejection is associated with increased percentages of C494 and metallothionein-positive cells as compared to steroid-sensitive cases, (3) that bronchiolitis obliterans was associated with a higher percentage of cells with drug-resistant antigen expression, and (4) that steroid-resistant bronchiolitis obliterans is associated with the highest percentage of C494 and metallothionein-positive cells in the five clinical situations studied. P-glycoprotein and metallothionein expression may be a marker of aggressive or persistent cases of acute rejection and bronchiolitis obliterans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Acute Disease
  • Bronchiolitis Obliterans / drug therapy
  • Bronchiolitis Obliterans / etiology
  • Bronchiolitis Obliterans / pathology
  • Chronic Disease
  • Drug Resistance*
  • Graft Rejection* / pathology
  • Humans
  • Immunohistochemistry
  • Lung / chemistry
  • Lung / pathology
  • Lung Transplantation* / adverse effects
  • Membrane Glycoproteins / analysis
  • Metallothionein / analysis
  • Steroids / therapeutic use

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Membrane Glycoproteins
  • Steroids
  • Metallothionein